737 related articles for article (PubMed ID: 29904241)
21. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
22. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
[TBL] [Abstract][Full Text] [Related]
23. The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
Wieczorska K; Stolarek M; Stec R
Clin Colorectal Cancer; 2020 Mar; 19(1):5-12. PubMed ID: 31678050
[TBL] [Abstract][Full Text] [Related]
24. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
Shah MS; DeSantis TZ; Weinmaier T; McMurdie PJ; Cope JL; Altrichter A; Yamal JM; Hollister EB
Gut; 2018 May; 67(5):882-891. PubMed ID: 28341746
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer and gut microbiota studies in China.
Wang Z; Dan W; Zhang N; Fang J; Yang Y
Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
Sobhani I; Bergsten E; Couffin S; Amiot A; Nebbad B; Barau C; de'Angelis N; Rabot S; Canoui-Poitrine F; Mestivier D; Pédron T; Khazaie K; Sansonetti PJ
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24285-24295. PubMed ID: 31712445
[TBL] [Abstract][Full Text] [Related]
27. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
28. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
29. Potential of fecal microbiota for early-stage detection of colorectal cancer.
Zeller G; Tap J; Voigt AY; Sunagawa S; Kultima JR; Costea PI; Amiot A; Böhm J; Brunetti F; Habermann N; Hercog R; Koch M; Luciani A; Mende DR; Schneider MA; Schrotz-King P; Tournigand C; Tran Van Nhieu J; Yamada T; Zimmermann J; Benes V; Kloor M; Ulrich CM; von Knebel Doeberitz M; Sobhani I; Bork P
Mol Syst Biol; 2014 Nov; 10(11):766. PubMed ID: 25432777
[TBL] [Abstract][Full Text] [Related]
30. Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer.
Liu X; Cheng Y; Shao L; Ling Z
Biomed Res Int; 2020; 2020():2948282. PubMed ID: 32280686
[TBL] [Abstract][Full Text] [Related]
31. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
32. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
33. Microbial Interactions and Interventions in Colorectal Cancer.
Van Raay T; Allen-Vercoe E
Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
[TBL] [Abstract][Full Text] [Related]
34. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
[TBL] [Abstract][Full Text] [Related]
35. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
36. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
37. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
38. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
39. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
Kong F; Cai Y
Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
[TBL] [Abstract][Full Text] [Related]
40. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]